6533b86dfe1ef96bd12c9b59
RESEARCH PRODUCT
“Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”
Sergio Palmerisubject
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2004-01-01 |